Kisspeptin Administration Subcutaneously to Patients With IHH
Kisspeptin Administration Subcutaneously to Patients With IHH
Recruiting · NCT05896293 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Kisspeptin Administration Subcutaneously to Patients With IHH | endocrine system disorder, gonadal disorder, hypogonadism, hypogonadotropic hypogonadism, hypogonadotropic hypogonadism 7 with or without anosmia | Recruiting | Phase 2 | 2026-07-13 | NCT05896293 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stephanie B. Seminara, MD | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |